MEDANTA · Healthcare
Global Health Ltd. reported revenue of ₹809 cr for January to March 2024, — on the year and −3.2% on the quarter.
Operating profit (EBITDA) was ₹179 cr, a margin of 22.1%, — on the year and −371 bps on the quarter.
Net profit was ₹127 cr, — on the year and +2.4% on the quarter, with earnings per share of ₹4.74.
A hospital chain grows by filling beds and lifting revenue per bed. New hospitals dilute margins in their first years, so a margin dip during expansion is not on its own a sign of weakness. The quarterly statements do not carry occupancy, revenue per occupied bed and new beds added; those come with the filing read.
On earnings per share of ₹17.81 over the last four quarters, the stock at ₹1,427.10 trades at 80.1 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow filed with this quarter, the auditor's review, segment results, one-off items line by line and what management said on the call.
A lower tax rate lifted profit. Is the lower rate going to last?
Source: Quarterly statements
Could not run on this quarter: Headline vs core profit, Exceptional items that recur, Operating margin on the year, Depreciation falling, Finance cost rising, Swing to loss or profit, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
This quarter's filing carries a balance sheet and a cash flow statement. The cash, receivables and borrowing checks run once the filing read is in.
| Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹836 cr | ₹809 cr | ₹861 cr | ₹957 cr | ₹943 cr | ₹931 cr | ₹1,031 cr | ₹1,099 cr | ₹1,121 cr | ₹1,159 cr | ₹1,304 cr | ₹1,469 cr |
| YoY | — | — | +10% | +13% | +13% | +15% | +20% | +15% | +19% | +24% | +26% | +34% |
| EBITDA margin | 25.8% | 22.1% | 21.6% | 23.8% | 25.2% | 24.2% | 24.0% | 21.0% | 19.4% | 21.1% | 22.0% | 25.2% |
| Other income, % of PBT | 10% | 19% | 15% | 10% | 8% | −20% | 10% | 10% | −13% | 20% | 10% | 8% |
| Exceptional items | — | — | — | — | — | — | — | ₹16.0 cr | — | — | — | — |
| Tax rate | 28% | 11% | 26% | 28% | 24% | 24% | 24% | 21% | 21% | 24% | 26% | 26% |
| Net profit | ₹124 cr | ₹127 cr | ₹106 cr | ₹131 cr | ₹143 cr | ₹101 cr | ₹159 cr | ₹158 cr | ₹95.0 cr | ₹142 cr | ₹157 cr | ₹219 cr |
| YoY | — | — | +4% | +5% | +15% | −20% | +50% | +21% | −34% | +41% | −1% | +38% |
| Core profit YoY | — | — | −3% | +9% | +12% | +38% | +54% | +1% | −22% | −6% | +2% | +65% |
| EPS | ₹4.61 | ₹4.74 | ₹3.96 | ₹4.87 | ₹5.32 | ₹3.78 | ₹5.92 | ₹5.89 | ₹3.54 | ₹5.36 | ₹5.91 | ₹8.21 |
| Flags | · | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | 1 | 1 | 2 | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Global Health Ltd. reported revenue of ₹809 cr (— on the year) and net profit of ₹127 cr (— on the year) for January to March 2024.
1 check raised a question: A lower tax rate lifted profit. Is the lower rate going to last?
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.